Ultimovacs (Norway)

Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention

Aikaterini Nasi, Stéphanie McArdle, Gustav Gaudernack et al. · Toxicology Reports · 2020 · 98 citations · Full text

Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer

Wolfgang Lilleby, Gustav Gaudernack, Paal Brunsvig et al. · Cancer Immunology Immunotherapy · 2017 · 95 citations · Full text

Vaccination, Urology, Genitourinary Cancer +9

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial

Elin Aamdal, Else Marit Inderberg, Espen B. Ellingsen et al. · Frontiers in Immunology · 2021 · 40 citations · Full text

Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer

Paal Brunsvig, Tormod Kyrre Guren, Marta Nyakas et al. · Frontiers in Immunology · 2020 · 39 citations · Full text

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials

Espen B. Ellingsen, Elin Aamdal, Tormod Kyrre Guren et al. · Journal for ImmunoTherapy of Cancer · 2022 · 36 citations · Full text